Published ahead of print on May 6, 2004, doi:10.1164/rccm.200305-648OC
Am. J. Respir. Crit. Care Med., Volume 170, Number 4, August 2004, 400-407
A more recent version of this article appeared on August 15, 2004
Submitted on May 13, 2003
Accepted on May 4, 2004
Bronchiectasis, Exacerbation Indices and Inflammation in Chronic Obstructive Pulmonary Disease
Irem S Patel1, Ioannis Vlahos2, Tom MA Wilkinson1, Simon J Lloyd-Owen1, Gavin C Donaldson1, Mark Wilks3, Rodney H Reznek2, and Jadwiga A Wedzicha1*
1 Academic Unit of Respiratory Medicine, St. Bartholomew's and the Royal London Hospital School of Medicine and Dentistry, London, United Kingdom,
2 Academic Radiology, St. Bartholomew's and the Royal London Hospital School of Medicine and Dentistry, London, United Kingdom,
3 Microbiology and Virology Clinical Group, St. Bartholomew's and the Royal London Hospital NHS Trust, London, United Kingdom
* To whom correspondence should be addressed. E-mail: j.a.wedzicha{at}qmul.ac.uk.
Relationships between high-resolution computerised tomography (HRCT) findings in chronic obstructive pulmonary disease (COPD), and bacterial colonisation, airway inflammation or exacerbation indices are unknown. 54 COPD patients (mean (standard deviation) age 69 (7) years, forced expiratory volume in one second (FEV1) 0.96 (0.33) litres, FEV1% predicted 38.1 (13.9) %, FEV1% /forced vital capacity 40.9 (11.8) %, arterial partial pressure of oxygen 8.77 (1.11) kilopascals, 50.5 (33.5) smoking pack years) underwent high-resolution CT scans of the chest to quantify the presence and extent of bronchiectasis or emphysema. Exacerbation indices were determined from diary cards over 2 years. Quantitative sputum bacteriology and cytokine measurements were performed. 27/54 (50%) patients had bronchiectasis on HRCT, most frequently in the lower lobes (18/54, 33.3%). Patients with bronchiectasis had higher levels of airway inflammatory cytokines (p= 0.001). Lower lobe bronchiectasis was associated with lower airway bacterial colonisation (p = 0.004), higher sputum interleukin (IL) -8 levels (p = 0.001) and longer symptom recovery time at exacerbation (p = 0.001). No relationship was seen between exacerbation frequency and HRCT changes. Evidence of moderate lower lobe bronchiectasis on HRCT is common in COPD and is associated with more severe COPD exacerbations, lower airway bacterial colonisation and increased sputum inflammatory markers.
Key words: CT scanning, bronchiectasis, COPD, exacerbation, inflammation
This article has been cited by other articles:

|
 |

|
 |
 
S. Sethi and T. F. Murphy
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
November 27, 2008;
359(22):
2355 - 2365.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Murphy, A. L. Brauer, K. Eschberger, P. Lobbins, L. Grove, X. Cai, and S. Sethi
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
853 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A B Chang and D Bilton
Exacerbations in cystic fibrosis: 4 {middle dot} Non-cystic fibrosis bronchiectasis
Thorax,
March 1, 2008;
63(3):
269 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Parr, P. G. Guest, J. H. Reynolds, L. J. Dowson, and R. A. Stockley
Prevalence and Impact of Bronchiectasis in {alpha}1-Antitrypsin Deficiency
Am. J. Respir. Crit. Care Med.,
December 15, 2007;
176(12):
1215 - 1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Wedzicha and J. R. Hurst
Structural and Functional Co-conspirators in Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS,
December 1, 2007;
4(8):
602 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1056 - 1065.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E Hollandl and B. M Buttonl
Is there a role for airway clearance techniques in chronic obstructive pulmonary disease?
Chronic Respiratory Disease,
April 1, 2006;
3(2):
83 - 91.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Chapman, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, et al.
Epidemiology and costs of chronic obstructive pulmonary disease
Eur. Respir. J.,
January 1, 2006;
27(1):
188 - 207.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|